Advertisement

What Are the Phases of Chronic Myeloid Leukemia?

Chronic myeloid leukemia is staged into three phases, chronic, accelerated, and blast phase. Learn what these terms mean.

Medically reviewed in May 2022

Staging is a way of categorizing cancer based on how much it has progressed. Staging is useful when deciding on a treatment approach and determining what therapies may be most helpful for treating a particular cancer.

Many staging systems assign a number based on tumor size and if the cancer has spread beyond the initial tumor. Staging for leukemia is different, however, because it involves cancerous cells that circulate through the blood and typically do not form solid tumors fixed at a particular point in the body. Leukemia stages are assigned based on factors including blood cell counts, enlarged organs, enlarged lymph nodes, and damage to bones.

Healthcare providers do not use a numbered staging system for CML. Instead, CML is categorized into one of three phases. Phases are determined based on the number of blast cells contained in the blood and/or bone marrow. Blast cells are immature white blood cells that are found in elevated numbers in people who have myeloid leukemia.

Different healthcare providers and organizations may use different thresholds for the different phases of CML, but the basic guidelines are:

  • Chronic phase. The majority of people diagnosed with CML are diagnosed during this phase and many do not have any symptoms. In this phase, blood and bone marrow contain less than 10 percent blast cells.
  • Accelerated phase. CML is considered to be in the accelerated phase when blood and bone marrow samples show between 10 and 19 percent blast cells, but other factors may also be taken into account. These factors include levels of other types of white blood cells, as well as platelet counts and chromosomal changes in the leukemia cells.
  • Blast phase (also called blast crisis). This phase is categorized by blood and bone marrow samples that show blast cell percentages above 20, as well as large clusters of blast cells in bone marrow, and blast cells spreading to other tissues.

The phase of the CML is an important piece of information when deciding on an approach to treatment. Targeted therapies called tyrosine kinase inhibitors (TKIs) are the preferred treatment for chronic phase CML, but other therapies (such as immunotherapy and chemotherapy) may also play a role in treatment for some patients. TKIs may also be used in the treatment of accelerated phase and blast phase CML, though when CML has advanced, it can be more challenging to treat. If possible, a person with advanced phase CML will be treated with a stem cell transplant.

Beyond the phase of the CML, there are other factors a cancer care team will take into account when advising a person with CML about treatment. These factors include the person’s age, overall health, and medical history, as well as the symptoms they are experiencing. Genetic changes to the CML cells may be another important factor, and healthcare providers may test for specific genetic changes, which can help determine what therapies and drugs might prove most effective.

Sources:
NCI Dictionary. "Cancer Staging."
Cancer Treatment Centers of America. "Leukemia Stages."
Cancer.Net. "Leukemia - Chronic Lymphocytic - CLL: Stages."
Medscape. "Chronic Myelogenous Leukemia (CML) Staging."
American Cancer Society. "Phases of Chronic Myeloid Leukemia."
Cancer.Net. "Leukemia - Chronic Myeloid - CML: Phases."
UpToDate. "Patient education: Chronic myeloid leukemia (CML) in adults (Beyond the Basics)."
American Cancer Society. "Phases of Chronic Myeloid Leukemia."
American Cancer Society. "Treating Chronic Myeloid Leukemia by Phase."
Leukemia & Lymphoma Society. "Types of CML Treatment."
Cancer.Net. "Leukemia - Chronic Myeloid - CML: Types of Treatment."
Massimiliano Bonifacio, Fabio Stagno, Luigi Scaffidi, Mauro Krampera, and Francesco Di Raimondo. "Management of Chronic Myeloid Leukemia in Advanced Phase." Frontiers in Oncology, 2019. Vol. 9.
Cancer Research UK. "Decisions about your treatment."
Puligundla Krishna Chaitanya, Karnam Ashok Kumar, Bala Stalin, Gundeti Sadashivudu, and Maddali Lakshmi Srinivas. "The Role of Mutation Testing in Patients with Chronic Myeloid Leukemia in Chronic Phase after Imatinib Failure and Their Outcomes after Treatment Modification: Single-institutional Experience Over 13 Years." Indian Journal of Medical and Pediatric Oncology, 2017. Vol. 38, No. 3.

Featured Content

video

3 Tips for Success With TKI Treatment

Watch this video to learn how to get the most out of this treatment for chronic myeloid leukemia.
article

Coping with the Mental Stress of CML

Why and how to make mental wellbeing a priority in your treatment for chronic myeloid leukemia.
article

How Chronic Myeloid Leukemia Affects the Body

Learn how CML disrupts the normal production of blood cells and the ways this can impact the body.
article

5 Answers About Chronic Myeloid Leukemia

Roughly 15 percent of leukemias are chronic myeloid leukemia. Learn about CML phases, treatments, and how it differs from acute myeloid leukemia.
article

Treating CML: What Happens if a TKI Stops Working

If a TKI is not effective against CML, there are a number of other treatments your healthcare providers may recommend.